Louis Health Care System have systematically evaluated health outcomes among more than 2 million people with diabetes taking the popular weight-loss drugs
What if I don't want to stay on medication long-term
Among the outcome estimates, significant reductions were reported in 13 of 17 for major adverse cardiovascular events (MACE), 5 of 8 for cardiovascular mortality, 3 of 4 for cardiovascular disease (CVD) events, 1 of 3 for cardiovascular death, and 1 of 1 for composite cardiovascular outcomes
Longer-acting GLP-1 analogs that can be administered once each month are currently in clinical trials
Benefits Beyond Weight Loss What sets GLP-1s apart is their ability to complement other wellness and body-contouring treatments, creating a holistic path to improved confidence and quality of life
Eat carrots, tomatoes, and green veggies